| 1 |
Microbial communities |
MWCNT |
10–100 mg/kg |
No visible effects |
(16a) |
| 2 |
Microbial communities |
MWCNT |
0,50,500, and 5000 mg/g |
Reduced enzyme activity, microbial biomass, and extracellular
enzyme activity |
(14e) |
| 3 |
Microbial communities |
Raw and acid treated, functionalized MWCNTs |
0–5000 mg/kg |
Bacterial community
composition affected but recovered afterward |
(16b) |
| 4 |
Escherichia coli |
SWNTs |
1–50 mg/mL |
Strong antimicrobial properties. |
(16c) |
| 5 |
Gram-negative Escherichia coli, Pseudomonas
aeruginosa, and gram-positive Staphylococcus aureus, Bacillus subtilis
|
SWCNT dispersed
and SWCNT agglomerates in saline solution |
5 g/mL |
Higher antibacterial activity
to gram-positive bacteria compared
to agglomerates. |
(9b) |
| 6 |
Bacterial and
fungal communities |
Carboxyl-functionalized SWCNTs |
0.5 mg/L |
Alteration
on Pseudomonas putida (Gram-negative)
phase transition temperatures. Higher doses had maximum biomass loss. |
(16d) |
| 7 |
Gram-positive, Gram-negative bacteria,
and fungal population |
SWCNT |
0.03–1 mg/g |
Reduced biomass
of microbe and fungal population |
(14g) |
